CARDIFF ONCOLOGY, INC. (CRDF) Net margin 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) net profit margin by fiscal year — reported net income divided by reported revenue.
-7732.0%FY2025 · since FY2016: -10287.7% → -7732.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7732.0% | -1080.4 pp |
| FY2024 | -6651.7% | +1840.3 pp |
| FY2023 | -8492.0% | +1534.9 pp |
| FY2022 | -10026.9% | -2146.4 pp |
| FY2021 | -7880.5% | -2605.4 pp |
| FY2020 | -5275.1% | +1434.6 pp |
| FY2019 | -6709.7% | -2358.7 pp |
| FY2018 | -4351.1% | +577.0 pp |
| FY2017 | -4928.1% | +5359.7 pp |
| FY2016 | -10287.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice